Effect of ovariectomy on the in vitro and in vivo activation of carcinogenic N-2-fluorenylhydroxamic acids by rat mammary gland and liver

Carcinogenesis

Volumn 17, Issue 11, 1996, Pages 2411-2418

  Ritter, Clare L ^a   Bennett, Kristen K ^b   Fullerton, Nancy F ^c   Beland, Frederick A ^c   Malejka Giganti, Danuta ^a,b,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^d VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ACYLTRANSFERASE; CARBOXYLESTERASE; CARCINOGEN; DNA; HYDROXAMIC ACID DERIVATIVE; MICROSOME ENZYME;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; CARCINOGEN DNA INTERACTION; CONTROLLED STUDY; CYTOSOL; DNA ADDUCT; ENZYME ACTIVITY; FEMALE; ISOTOPE LABELING; LIVER; LIVER METABOLISM; MAMMARY GLAND; METABOLIC ACTIVATION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

EID: 0029804385     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.11.2411     Document Type: Article

References (56)

1. Huggins, C.B. (1979) Experimental Leukemia and Mammary Cancer. Induction, Prevention, Cure. The University of Chicago Press, Chicago, IL.
2. Welsch, C.W. (1985) Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute 10 Charles Brenton Huggins. Cancer Res., 45, 3415-3443.
3. Miller, E.C. Miller, J.A. and Hartmann, H.A. (1961) N-Hydroxy-2-acetylaminofluorene: a metabolite of 2-acetylaminofluorene with increased carcinogenic activity in the rat. Cancer Res., 21, 815-824.
4. Miller, J.A., Wyatt, C.S., Miller, E.C. and Hartmann, H.A. (1961) The N-hydroxylation of 4-acetylaminobiphenyl by the rat and dog and the strong carcinogenicity of N-hydroxy-4-acetylaminobiphenyl in the rat. Cancer Res., 21, 1465-1473.
5. Gutmann, H.R., Galitski, S.B. and Foley, W.A. (1967) The conversion of noncarcinogenic aromatic amides to carcinogenic arylhydroxamic acids by synthetic N-hydroxylation. Cancer Res., 27, 1443-1455.
6. Gutmann, H.R., Leaf, D.S., Yost, Y., Rydell, R.E. and Chen, C.C. (1970) Structure-activity relationships of N-acylarylhydroxylamines in the rat. Cancer Res., 30, 1485-1498.
7. Malejka-Giganti, D., Gutmann, H.R. and Rydell, R.E. (1973) Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids. Cancer Res., 33, 2489-2497.
8. Malejka-Giganti, D., Rydell, R.E. and Gutmann, H.R. (1977) Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates. Cancer Res., 37, 111-117.
9. Malejka-Giganti, D. (1981) Activation of certain N-arylacetamides and N-arylacetohydroxamic acids in relation to mammary gland tumorigenesis in the rat. Natl Cancer Inst. Monogr., 58, 69-77.
10. Allaben, W.T., Weeks, C.E., Weiss, C.C., Burger, G.T. and King, C.M. (1982) Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: Relationship to metabolic activation. Carcinogenesis, 3, 233-240.
11. King, C.M., Traub, N.R., Lortz, Z.M. and Thissen, M.R. (1979) Metabolic activation of arylhydroxamic acids by N,O-acyltransferase of rat mammary gland. Cancer Res., 39, 3369-3372.
12. Shirai, T., Fysh, J.M., Lee, M.-S., Vaught, J.B. and King, C.M. (1981) Relationship of metabolic activation of N-hydroxy-N-acylarylamines to biological response in the liver and mammary gland of the female CD rat. Cancer Res., 41, 4346-4353.
13. Neumann, H.-G. (1986) The role of DNA damage in chemical carcinogenesis of aromatic amines. J. Cancer Res. Clin. Oncol., 112, 100-106.
14. Beland, F.A. and Poirier, M.C. (1989) DNA adducts and carcinogenesis. In Sirica, A.E. (ed.), The Pathobiology of Neoplasia. Plenum Publishing Corp., New York, pp. 57-80.
15. Beland, F.A. and Kadlubar, F.F. (1990) Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. In Cooper, C.S. and Grober, P.L. (eds), Handbook of Experimental Pharmacology. Springer-Verlag, Berlin, Vol. 94/I, pp. 267-325.
16. Allaben, W.T., Weis, C.W., Fullerton, N.F. and Beland, F.A. (1983) Formation and persistence of DNA adducts from the carcinogen N-hydroxy-2-acetylaminofluorene in rat mammary gland in vivo. Carcinogenesis, 4, 1067-1070.
17. Ritter, C.L. and Malejka-Giganti, D. (1994) Activation of the carcinogens N-hydroxy-N-2-fluorenylbenzamide and N-hydroxy-N-2-fluorenylacetamide via deacylations and acetyl transfers by rat peritoneal serosa and liver. Carcinogenesis, 15, 163-170.
18. Malejka-Giganti, D., Ritter, C.L., Fullerton, N.F. and Beland, F.A. (1994) Detection of N-(deoxyguanosin-8-yl)-2-fluorenamine in DNA of peritoneal serosa and liver after intraperitoneal exposure of rats to N-hydroxy-N-2-fluorenylbenzamide or N-hydroxy-N-2-fluorenylacetamide. Carcinogenesis, 15, 2883-2890.
19. Ritter, C.L. and Malejka-Giganti, D. (1995) Debenzoylating and deacetylating activities of rat liver and mammary gland microsomes. Biochem. Pharmacol., 50, 1265-1272.
20. Flammang, T.J. and Kadlubar, F.F. (1986) Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2′-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxyarylamines in relation to tissue and species differences, other acyl donors and arylhydroxamic acid-dependent acyltransferase. Carcinogenesis, 7, 919-926.
21. Abu-Zeid, M., Yamazoe, Y. and Kato, R. (1992) Sulfotransferase-mediated DNA binding of N-hydroxyarylamines (amide) in liver cytosols from human and experimental animals. Carcinogenesis, 13, 1307-1314.
22. Bartsch, H., Dworkin, M., Miller, J.A. and Miller, E.C. (1972) Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-2-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver. Biochim. Biophys. Acta, 286, 272-298.
23. Gilissen, R.A.H.J., Ringer, D.P., Stavenuiter, H.J.F.C., Mulder, G.J. and Meerman, J.H.N. (1992) Sulfation of hydroxylamines and hydroxamic acids in liver cytosol from male and female rats and purified aryl sulfotransferase IV. Carcinogenesis, 13, 1699-1703.
24. 14 in the rat. Cancer Res., 13, 415-421.
25. Gutmann, H.R. and Kaplan, E. (1977) Separation and identification of metabolites of the arylamide, N-2-fluorenylacetamide, by high-pressure liquid chromatography. J. Chromatogr., 144, 136-140.
26. Hess, H.H., Lees, M.B. and Derr, J.E. (1978) A linear Lowry-Folin assay for both water-soluble and sodium dodecyl sulfate-solubilized proteins. Anal. Biochem., 85, 295-300.
27. Ritter, C.L. and Malejka-Giganti, D. (1982) Mixed function oxidase in the mammary gland and liver microsomes of lactating rats. Biochem. Pharmacol., 31, 239-247.
28. 1) mice. Carcinogenesis, 6, 1037-1045.
29. Beland, F.A., Dooley, K.L. and Casciano, D.A. (1979) Rapid isolation of carcinogen-bound DNA and RNA by hydroxyapatite chromatography. J. Chromatogr., 174, 177-186.
30. 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. Cancer Res., 45, 5656-5662.
31. 32P-Postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo[a]pyrene. Cancer Res., 46, 3046-3054.
32. Malejka-Giganti, D., Ritter, C.L. and Decker, R.W. (1992) Activation of the carcinogen N-hydroxy-N(2-fluorenyl)benzamide via chemical and enzymatic oxidations. Comparison to oxidations of the structural analogue N-hydroxy-N(2-fluorenyl)acetamide. Chem. Res. Toxicol., 5, 520-527.
33. Irving, C.C. (1979) Species and tissue variations in the metabolic activation of aromatic amines. In Griffin, A.C. and Shaw, C.R. (eds) Carcinogens: Identification and Mechanisms of Action. Raven Press, New York, pp. 211-227.
34. Wang, C.Y., Yamada, H., Morton, K.C., Zukowski, K., Lee, M.-S. and King, C.M. (1988) Induction of repair synthesis of DNA in mammary and urinary bladder epithelial cells by N-hydroxy derivatives of carcinogenic arylamines. Cancer Res., 48, 4227-4232.
35. Hosokawa, M., Maki, T. and Satoh, T. (1988) Differences in the induction of carboxylesterase isozymes in rat liver microsomes by xenobiotics. Biochem. Pharmacol., 37, 2708-2711.
36. McCracken, N.W., Blain, P.G. and Williams, F.M. (1993) Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. Biochem. Pharmacol., 45, 31-36.
37. Deimling, O.V. and Bocking, A. (1976) Esterases in histochemistry and ultrahistochemistry. Histochem. J., 8, 215-252.
38. Wick, M.J. and Hanna, P.E. (1990) Bioactivation of N-arylhydroxamic acids by rat hepatic N-acetyltransferase. Biochem. Pharmacol., 39, 991-1003.
39. Hein, D.W., Rustan, T.D., Bucher, K.D., Martin, W.J. and Furman, E.J. (1991) Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver. Drug Metab. Dispos., 19, 933-937.
40. Land, S.J., Zukowski, K., Lee, M.-S., Wang, C.Y. and King, C.M. (1993) Purification and characterization of a rat hepatic acetyltransferase that can metabolize aromatic amine derivatives. Carcinogenesis, 14, 1441-1449.
41. Debiec-Rychter, M., Land, S.J. and King, C.M. (1996) Histological localization of messenger RNAs for rat acetyltransferases that acetylate serotonin and genotoxic arylamines. Cancer Res., 56, 1517-1525.
42. Davis, C.D., Ghoshal, A., Schut, H.A.J. and Snyderwine, E.G. (1994) Metabolic activation of heterocyclic amine food mutagens in the mammary gland of lactating Fischer 344 rats. Cancer Lett., 84, 67-73.
43. Malejka-Giganti, D., Magat, W.J. and Decker, R.W. (1989) Modifications of hepatic microsomal 9-oxidation of N-2-fluorenylacetamide in response to gonadectomy and treatment of rats with phenobarbital or diethylnitrosamine. Xenobiotica, 19, 431-444.
44. Bartsch, H., Dworkin, C., Miller, E.C. and Miller, J.A. (1973) Formation of electrophilic N-acetoxyarylamines in cytosols from rat mammary gland and other tissues by transacetylation from the carcinogen N-hydroxy-4-acetylaminobiphenyl. Biochim. Biophys. Acta, 304, 42-55.
45. King, C.M. (1974) Mechanism of reaction, tissue distribution, and inhibition of arylhydroxamic acid acyltransferase. Cancer Res., 34, 1503-1515.
46. King, C.M. and Olive, C.W. (1975) Comparative effects of strain, species, and sex on the acyltransferase- and sulfotransferase-catalyzed activations of N-hydroxy-N-2-fluorenylacetamide. Cancer Res., 35, 906-912.
47. Kawakubo, Y., Manabe, S., Yamazoe, Y., Nishikawa, T. and Kato, R. (1988) Properties of cutaneous acetyltransferase catalyzing N- and O-acetylation of carcinogenic arylamines and N-hydroxyarylamine. Biochem. Pharmacol., 37, 265-270.
48. Roberts, S.M., Budinsky, R.A., Adams, L.E., Litwin, A. and Hess, E.V. (1985) Procainamide acetylation in strains of rat and mouse. Drug Metab. Dispos., 13, 517-519.
49. Ware, J.A., Divakaruni, P. and Svensson, C.K. (1995) Comparison of acetyl coenzyme A:arylamine N-acetyltransferase activity in the liver, kidney, and intestine of male and female rats from three strains. Drug Metab. Dispos., 23, 295-297.
50. Wang, C.Y., Zukowski, K., Lee, M.-S. and Sone, T. (1992) Purification and characterization of rat hepatic microsomal N,O-acyltransferases. Carcinogenesis, 13, 2017-2020.
51. DeBaun, J.R., Miller, E.C. and Miller, J.A. (1970) N-Hydroxy-2-acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver. Cancer Res., 30, 577-595.
52. Kadlubar, F.F., Miller, J.A. and Miller, E.C. (1976) Hepatic metabolism of N-hydroxy-N-methyl-4-aminoazobenzene and other N-hydroxy arylamines to reactive sulfuric acid esters. Cancer Res., 36, 2350-2359.
53. Kolanczyk, R.C., Rutks, I.R. and Gutmann, H.R. (1991) The catalytic effect of bovine serum albumin on the ortho rearrangement of the potential ultimate carcinogen, N-(sulfooxy)-2-(acetylamino)-fluorene, generated enzymatically from N-hydroxy-2-(acetylamino)-fluorene and evidence for substrate specificity of the enzymatic sulfonation of arythydroxamic acids. Chem. Res. Toxicol., 4, 187-194.
54. Irving, C.C. Janss, D.H. and Russell, L.T. (1971) Lack of N-hydroxy-2-acetylaminofluorene sulfotransferase activity in the mammary gland and Zymbal's gland of the rat. Cancer Res., 31, 387-391.
55. 14C and its N-hydroxy metabolite. J. Natl Cancer Inst., 49, 765-771.
56. Poirier, M.C. and Beland, F.A. (1994) DNA adduct measurements and tumor incidence during chronic carcinogen exposure in rodents. Environ. Health Perspect., 102, 161-165.